July 15, 2026—Leica Biosystems, an operating company of Danaher, has entered into a definitive agreement to acquire privately held StatLab Medical Products, a global developer and manufacturer of anatomic pathology products, from Linden Capital Partners and Audax Private Equity. Following the closing, StatLab will become part of Leica Biosystems.
StatLab provides a broad portfolio of products across the preanalytical and analytical histology workflow, from specimen collection and tissue processing through slide preparation and staining. Built on a strong reputation for quality, innovation, and customer partnership, StatLab shares Leica Biosystems’ commitment to advancing cancer diagnostics and improving outcomes for patients worldwide.
The transaction is expected to close by the end of this year and is subject to customary conditions, including receipt of applicable regulatory clearances. Financial terms of the acquisition were not disclosed.